Question

A 66-year-old man with new AF and CHA₂DS₂‑VASc 2 (age, HTN) asks about anticoagulation choice. He has no moderate‑to‑severe mitral stenosis and no mechanical valve. Best option?

Accepted Answer

DOAC preferred over warfarin

Answer

Warfarin preferred over DOAC

Answer

Aspirin monotherapy

Answer

No therapy

Answer

Dual antiplatelet therapy

Practice question

A 66-year-old man with new AF and CHA₂DS₂‑VASc 2 (age, HTN) asks about anticoagulation choice. He has no moderate‑to‑severe mitral stenosis and no mechanical valve. Best option?